Preclinical studies have shown that the CSF-1/CSF-1R signaling cascade not only decreases the number of infiltrating TAMs but also repolarizes M2-like to M1-like phenotypes within the tumor microenvironment [13,65]. The gene discussed is CSF1R; the disease is neoplasm.